% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Liu:863043,
author = {Liu, Jingjin and Nolte, Kay and Brook, Gary and
Liebenstund, Lisa and Weinandy, Agnieszka and Höllig, Anke
and Veldeman, Michael and Willuweit, Antje and Langen,
Karl-Josef and Rossaint, Rolf and Coburn, Mark},
title = {{P}ost-stroke treatment with argon attenuated brain injury,
reduced brain inflammation and enhanced {M}2
microglia/macrophage polarization: a randomized controlled
animal study},
journal = {Critical care},
volume = {23},
number = {1},
issn = {1364-8535},
address = {Heidelberg},
publisher = {Springer},
reportid = {FZJ-2019-03165},
pages = {198},
year = {2019},
abstract = {BackgroundIn recent years, argon has been shown to exert
neuroprotective effects in an array of models. However, the
mechanisms by which argon exerts its neuroprotective
characteristics remain unclear. Accumulating evidence imply
that argon may exert neuroprotective effects via modulating
the activation and polarization of microglia/macrophages
after ischemic stroke. In the present study, we analyzed the
underlying neuroprotective effects of delayed argon
application until 7 days after reperfusion and explored the
potential mechanisms.MethodsTwenty-one male Wistar rats
underwent transient middle cerebral artery occlusion or sham
surgery randomly for 2 h using the endoluminal thread
model. Three hours after transient middle cerebral artery
occlusion induction and 1 h after reperfusion, animals
received either $50\%$ vol $Argon/50\%$ vol O2 or $50\%$ vol
$N2/50\%$ vol O2 for 1 h. The primary outcome was the
6-point neuroscore from 24 h to d7 after reperfusion.
Histological analyses including infarct volume, survival of
neurons (NeuN) at the ischemic boundary zone, white matter
integrity (Luxol Fast Blue), microglia/macrophage activation
(Iba1), and polarization (Iba1/Arginase1 double staining) on
d7 were conducted as well. Sample size calculation was
performed using nQuery Advisor + nTerim 4.0. Independent t
test, one-way ANOVA and repeated measures ANOVA were
performed, respectively, for statistical analysis (SPSS
23.0).ResultsThe 6-point neuroscore from 24 h to d7 after
reperfusion showed that tMCAO Ar group displayed
significantly improved neurological performance compared to
tMCAO N2 group (p = 0.026). The relative numbers of
NeuN-positive cells in the ROIs of tMCAO Ar group
significantly increased compared to tMCAO N2 group
(p = 0.010 for cortex and p = 0.011 for subcortex).
Argon significantly suppressed the microglia/macrophage
activation as revealed by Iba1 staining (p = 0.0076) and
promoted the M2 microglia/macrophage polarization as
revealed by Iba1/Arginase 1 double staining
(p = 0.000095).ConclusionsArgon administration with a
3 h delay after stroke onset and 1 h after reperfusion
significantly alleviated neurological deficit within the
first week and preserved the neurons at the ischemic
boundary zone 7 days after stroke. Moreover, argon reduced
the excessive microglia/macrophage activation and promoted
the switch of microglia/macrophage polarization towards the
anti-inflammatory M2 phenotype. Studies making efforts to
further elucidate the protective mechanisms and to benefit
the translational application are of great value.},
cin = {INM-4},
ddc = {610},
cid = {I:(DE-Juel1)INM-4-20090406},
pnm = {573 - Neuroimaging (POF3-573)},
pid = {G:(DE-HGF)POF3-573},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:31159847},
UT = {WOS:000470127200001},
doi = {10.1186/s13054-019-2493-7},
url = {https://juser.fz-juelich.de/record/863043},
}